Annual Scientific Meeting

Each year, Accelerate Brain Cancer Cure hosts a scientific meeting to give researchers, investors, policy leaders, and industry leaders the chance to discuss progress in brain cancer research.  The meeting serves as a catalyst for innovation and allows scientists to form collaborations with biotechnology and pharmaceutical companies that can drive discoveries from lab to the clinic.

2008 Annual Scientific Meeting


Thursday, November 13
Meeting Location: Smithsonian Institution Building, the Castle
1000 Jefferson Drive, SW
Washington, DC

8:30 – 9:00 AM Welcome, Chairman’s Remarks and Introductions
Smithsonian Castle, Castle Common
Steve Case
Chairman, Accelerate Brain Cancer Cure
Max Wallace
Chief Executive Officer, Accelerate Brain Cancer Cure
9:00 – 10:30 AM Panel 1. Genomic analyses of GBM: What have we learned from this landmark work and where can it lead us?
Introduction by Dr. Francis Collins Former Director and now Special Volunteer, National Human Genome Research Institute
Moderated by Dr. Francis Collins
Dr. Lynda Chin
Associate Professor, Department of Dermatology, Harvard Medical School and Department of Medical Oncology , Dana-Farber Cancer Institute
Dr. Paul Mischel
Professor, Department of Pathology and Laboratory Medicine and Molecular Medicine Pharmacology, David Geffen UCLA School of Medicine and Vice President, American Society of Clinical Investigation
Dr. Will Parsons Assistant Professor, Pediatric Hematology-Oncology, Baylor College of Medicine, and Assistant Professor (visiting), Kimmel Cancer Center at Johns Hopkin
Discussion to follow.
- 15 min. break -
10:45 – 12:15 PM Panel 2. Translating the GBM genome into the clinic: Short-term and long-term implications for patient care and new drug development.
Moderated by Dr. Susan Chang
Professor of Neurological Surgery, UCSF
Dr. Alfred Yung
Chair, Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center
Dr. David Parkinson
President and Chief Executive Officer, Nodality, Inc.
Dr. Philippe Bishop
Vice President, Clinical Development, Avastin

1:00 – 2:30 PM Panel 3. Discussion of the Most Current Clinical Approaches to Treating GBM.
Moderated by Dr. David Agus
Research Director, Louis Warschaw Prostate Cancer Center
Director, Spielberg Family Center for Applied Proteomics, Cedars-Sinai Medical Center
- 15 min. break -
2:45 – 4:00 PM Panel 4. GBM and the National Agenda: New initiatives at the NCI and the introduction of a new healthcare bill in Congress.
Moderated by Max Wallace
Dr. Carolyn Compton
Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute
Dr. Kavita Patel
Deputy Staff Director of the Senate Health, Education, Labor and Pensions Committee
Dr. Ken Buetow
Associate Director for Biomedical and Information Technology, National Cancer Institute
5:00 – 6:00 PM Cocktail Reception
Indian Treaty Room
The White House Complex
The Eisenhower Executive Office Building
1600 Pennsylvania Avenue
Washington, DC
Friday, November 14
8:30 – 9:45 AM Panel 5. Brain cancer and the physical sciences.
Dr. Sanjay Kumar
Assistant Professor of Bioengineering, University of California, Berkeley
Dr. Robert Urban
Executive Director, Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology
9:45 – 10:45 AM Closing Keynote Address
“A Systems Approach to Brain Cancer: Science, Technology and Strategic Partnerships”
Dr. Leroy Hood
Founder and President, Institute for Systems Biology
10:45 – 11:00 AM Closing Remarks
Steve Case
Chairman, Accelerate Brain Cancer Cure